000 | 01934 a2200541 4500 | ||
---|---|---|---|
005 | 20250513112738.0 | ||
264 | 0 | _c19970407 | |
008 | 199704s 0 0 eng d | ||
022 | _a0027-8424 | ||
024 | 7 |
_a10.1073/pnas.94.5.2007 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHara, H | |
245 | 0 | 0 |
_aInhibition of interleukin 1beta converting enzyme family proteases reduces ischemic and excitotoxic neuronal damage. _h[electronic resource] |
260 |
_bProceedings of the National Academy of Sciences of the United States of America _cMar 1997 |
||
300 |
_a2007-12 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aBlotting, Western |
650 | 0 | 4 |
_aBrain _xdrug effects |
650 | 0 | 4 |
_aBrain Ischemia _xdrug therapy |
650 | 0 | 4 | _aCaspase 1 |
650 | 0 | 4 | _aCaspase 3 |
650 | 0 | 4 | _aCaspases |
650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
650 | 0 | 4 |
_aCerebrovascular Disorders _xdrug therapy |
650 | 0 | 4 |
_aCysteine Endopeptidases _xmetabolism |
650 | 0 | 4 |
_aCysteine Proteinase Inhibitors _xpharmacology |
650 | 0 | 4 |
_aGene Expression _xgenetics |
650 | 0 | 4 |
_aInterleukin-1 _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNeurons _xdrug effects |
650 | 0 | 4 |
_aNeurotoxins _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptors, Glutamate _xmetabolism |
650 | 0 | 4 | _aReperfusion |
700 | 1 | _aFriedlander, R M | |
700 | 1 | _aGagliardini, V | |
700 | 1 | _aAyata, C | |
700 | 1 | _aFink, K | |
700 | 1 | _aHuang, Z | |
700 | 1 | _aShimizu-Sasamata, M | |
700 | 1 | _aYuan, J | |
700 | 1 | _aMoskowitz, M A | |
773 | 0 |
_tProceedings of the National Academy of Sciences of the United States of America _gvol. 94 _gno. 5 _gp. 2007-12 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1073/pnas.94.5.2007 _zAvailable from publisher's website |
999 |
_c9039056 _d9039056 |